Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.
Department of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.
Eur J Surg Oncol. 2018 Oct;44(10):1610-1618. doi: 10.1016/j.ejso.2018.07.051. Epub 2018 Jul 31.
The liver is the most common site of colorectal liver metastases (CRLM) and surgical resection improves overall survival in selected patients. Here, we investigate outcomes and relevant prognostic factors after repeated hepatic resections for CRLM.
From a prospective database, 578 patients who underwent 788 resections of colorectal liver metastases were included into this study. In total, 169 patients underwent a second and 41 patients had a third operation due to intrahepatic metastatic recurrence. Univariate and multivariate analyses were performed to determine prognostic risk factors.
5-year overall survival was 36.7% (95% CI: 30.2%; 43.2%) and 10-year survival was 20.3% (95% CI: 7.6%; 33.0%) in patients undergoing single resection. In patients undergoing a second or third resection, 5- and 10-year survival rates were 56.6% (95% CI: 45.0%; 68.2%) and 21.9% (95% CI: 6.8%; 37.0%) or 53.2% (95% CI: 32.4%; 74.0%) and 25.4%, respectively. In patients undergoing single resection, established markers (number, size and pattern of CRLM [p = 0.030/0.015/<0.001], R-status [p = 0.001], surgical/medical complications [p = 0.001/0.008], CEA-level [p = 0.001] and Fong-Score [p = 0.02]) were significantly associated with survival. In patients undergoing three resections, the only predictive markers were pT-stage of the primary tumor in univariate analysis (p = 0.013) and metachronous metastasis and medical complications in multivariate analysis (p = 0.001/0.025). The Fong-Score had no predictive value in patients undergoing two (p = 0.08) or three (p = 0.7) resections.
Established prognostic indicators are not applicable in patients undergoing repeated CRLM resection. In a highly-selected group of patients, repeated hepatic resections can be performed safely with favorable long-term outcomes.
肝脏是结直肠癌肝转移(CRLM)最常见的部位,手术切除可提高选定患者的总体生存率。在这里,我们研究了多次肝切除术治疗 CRLM 的结果和相关预后因素。
从一个前瞻性数据库中,纳入了 578 名接受了 788 次结直肠肝转移切除术的患者。共有 169 名患者接受了第二次手术,41 名患者因肝内转移复发接受了第三次手术。进行了单因素和多因素分析以确定预后危险因素。
行单次切除术的患者 5 年总生存率为 36.7%(95%CI:30.2%;43.2%),10 年生存率为 20.3%(95%CI:7.6%;33.0%)。行第二次或第三次切除术的患者 5 年和 10 年的生存率分别为 56.6%(95%CI:45.0%;68.2%)和 21.9%(95%CI:6.8%;37.0%)或 53.2%(95%CI:32.4%;74.0%)和 25.4%。在接受单次切除术的患者中,已确立的标志物(CRLM 的数量、大小和模式[P=0.030/0.015/<0.001]、R 状态[P=0.001]、手术/医疗并发症[P=0.001/0.008]、CEA 水平[P=0.001]和 Fong 评分[P=0.02])与生存率显著相关。在接受三次切除术的患者中,单因素分析中唯一的预测标志物是原发肿瘤的 pT 分期(p=0.013),多因素分析中是同时性转移和医疗并发症(p=0.001/0.025)。Fong 评分在接受两次(p=0.08)或三次(p=0.7)切除术的患者中没有预测价值。
在接受多次 CRLM 切除术的患者中,已确立的预后指标并不适用。在高度选择的患者组中,多次肝切除术可安全进行,且具有良好的长期结果。